NL-OMON33222撤回不适用
Reduction of antibiotic use in the ICU: Procalcitonin guided versus conventional antibiotic therapy in patients with sepsis in the ICU - Procalcitonin in the IC
Alysis Zorggroep0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patients admitted to the ICU
- •2. Age >18 years
- •3. Antibiotic therapy for sepsis with a suspected or proven focus of infection
排除标准
- •1. Age <18 years
- •2. Pregnancy
- •3. Infection or presumed infection requiring prolonged antibiotic therapy (osteomyelitis, meningitis, endocarditis, septic arthritis, mediastinitis, tuberculosis, Pneumocystis jiroveci pneumonia, Toxoplasmosis, Legionellosis, Listeriosis)
- •4. Indication for prolonged systemic prophylactic antibiotic therapy
- •5. Severe viral or parasitic infections (hemorrhagic fever, malaria)
- •6. Antibiotic therapy started 48 hours before enrollment
- •7. Severe immunocompromised patients (AIDS with a CD4 count<200cells/mm3, severe neutropenia(<500 neutrophils/mm3), patients undergoing immunosuppressive therapy after solid organ transplantation)
- •8. Patients foregoing lifesustaining treatment.
研究者
相似试验
招募中
不适用
Reducing the prescription of antibiotics in newborn infants suspected for having an early onset sepsis.Early Onset SepsisInfection1000401810028920NL-OMON31252niversitair Medisch Centrum Groningen920
撤回
不适用
Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICUIntensive CareSepsisNCT00987818Rijnstate Hospital
尚未招募
1 期
Cost of hospital stayCTRI/2024/03/063438Poosa Sravanthi
已完成
不适用
Antibiotic Concentration in Critically ill intensive care unit (ICU) patients in SwedeCritical illnessInfection - Other infectious diseasesSepsisSeptic shockACTRN12616000167460ppsala university150
招募中
不适用
Reducing the prescription of antibiotics in newborn infants, suspected for an early onset sepsis.Early onset sepsisNeonatal sepsisCytokinesAntibioticsVroege infectieNeonatale infectieCytokinenAntibioticaNL-OMON22612o sponsor900